173 related articles for article (PubMed ID: 19390937)
1. Efficacy of adjuvant chemotherapy using tegafur-based regimen for curatively resected gastric cancer: update of a meta-analysis.
Oba K
Int J Clin Oncol; 2009 Apr; 14(2):85-9. PubMed ID: 19390937
[TBL] [Abstract][Full Text] [Related]
2. [Overview of clinical trials on adjuvant chemotherapy for curatively resected gastric cancer].
Sasako M; Sano T; Katai H; Okajima K; Maruyama K
Gan To Kagaku Ryoho; 1994 Oct; 21 Suppl 3():384-94. PubMed ID: 7986119
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant mitomycin and fluorouracil followed by oral uracil plus tegafur in serosa-negative gastric cancer: a randomised trial. Gastric Cancer Surgical Study Group.
Nakajima T; Nashimoto A; Kitamura M; Kito T; Iwanaga T; Okabayashi K; Goto M
Lancet; 1999 Jul; 354(9175):273-7. PubMed ID: 10440302
[TBL] [Abstract][Full Text] [Related]
4. [Adjuvant chemotherapy using S-1 for curatively resected gastric cancer-the nationwide clinical trial].
Sasako M; Saka M; Fukagawa T; Katai H; Sano T
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():110-6. PubMed ID: 16897984
[TBL] [Abstract][Full Text] [Related]
5. [Comparative clinical study of adjuvant postoperative chemotherapy (5-FU, Tegafur, 5-FU + MMC) in curatively resected cases of gastric cancer. Study Group on 5-FU Oral Adjuvant Chemotherapy in Gastric Cancer].
Nakajima T; Miwa K; Ohmori Y; Sakabe T; Fujii M; Kajitani T
Gan To Kagaku Ryoho; 1996 Aug; 23(9):1161-8. PubMed ID: 8751804
[TBL] [Abstract][Full Text] [Related]
6. [Current status and problem of adjuvant chemotherapy for curatively resected gastric cancer].
Saka M; Sasako M; Katai H; Sano T
Gan To Kagaku Ryoho; 2000 Nov; 27(13):2033-42. PubMed ID: 11103234
[TBL] [Abstract][Full Text] [Related]
7. [Safety and effectiveness of oxaliplatin combined with capecitabine or oxaliplatin combined with S-1 neoadjuvant chemotherapy in the treatment of advanced gastric cancer].
Xie BW; Zang L; Ma JJ; Sun J; Yang X; Wang ML; Lu AG; Hu WG; Zheng MH
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):138-144. PubMed ID: 33508919
[No Abstract] [Full Text] [Related]
8. Sequential paclitaxel followed by tegafur and uracil (UFT) or S-1 versus UFT or S-1 monotherapy as adjuvant chemotherapy for T4a/b gastric cancer (SAMIT): a phase 3 factorial randomised controlled trial.
Tsuburaya A; Yoshida K; Kobayashi M; Yoshino S; Takahashi M; Takiguchi N; Tanabe K; Takahashi N; Imamura H; Tatsumoto N; Hara A; Nishikawa K; Fukushima R; Nozaki I; Kojima H; Miyashita Y; Oba K; Buyse M; Morita S; Sakamoto J
Lancet Oncol; 2014 Jul; 15(8):886-93. PubMed ID: 24954805
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of adjuvant chemotherapy for curatively resected gastric cancer with S-1.
Hisashige A; Sasako M; Nakajima T
BMC Cancer; 2013 Oct; 13():443. PubMed ID: 24079752
[TBL] [Abstract][Full Text] [Related]
10. [Multihospital co-operative study of post-operative adjuvant chemotherapy in the treatment of gastric cancer-(Part 3). Comparisons between tegafur and UFT. North Kyushu Co-operative Study Group for Cancer Chemotherapy].
Arima S; Yamamoto H; Hisatsugu T; Ohkuma R; Ohsato K; Abe R; Nakamura Y; Fukuyama N; Yamanouchi A; Taira A
Gan To Kagaku Ryoho; 1991 Mar; 18(3):443-9. PubMed ID: 1900685
[TBL] [Abstract][Full Text] [Related]
11. Treatment using oxaliplatin and S-1 adjuvant chemotherapy for pathological stage III gastric cancer: a multicenter phase II study (TOSA trial) protocol.
Namikawa T; Maeda H; Kitagawa H; Oba K; Tsuji A; Yoshikawa T; Kobayashi M; Hanazaki K
BMC Cancer; 2018 Feb; 18(1):186. PubMed ID: 29439671
[TBL] [Abstract][Full Text] [Related]
12. [Safety and efficacy of adjuvant chemotherapy with oxaliplatin and S-1 for patients with locally advanced gastric cancer after D2 lymph nodes dissection].
Bao YD; Zhang H; Dong L; Jiang KW; Ye YJ; Wang S; Zhou J
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):145-152. PubMed ID: 33508920
[No Abstract] [Full Text] [Related]
13. A phase II trial of capecitabine plus cisplatin (XP) for patients with advanced gastric cancer with early relapse after S-1 adjuvant therapy: XParTS-I trial.
Nishikawa K; Tsuburaya A; Yoshikawa T; Takahashi M; Tanabe K; Yamaguchi K; Yoshino S; Namikawa T; Aoyama T; Rino Y; Kawada J; Tsuji A; Taira K; Kimura Y; Kodera Y; Hirashima Y; Yabusaki H; Hirabayashi N; Fujitani K; Miyashita Y; Morita S; Sakamoto J
Gastric Cancer; 2018 Sep; 21(5):811-818. PubMed ID: 29488122
[TBL] [Abstract][Full Text] [Related]
14. [An evaluation of perioperative and continuous infusion of tegafur as surgical adjuvant chemotherapy of resected gastric cancer].
Tsugita M; Takasaki K; Yagawa A; Yamamoto M; Aruga A; Hayashi T; Shimizu Y; Kitamura Y; Suzuki H; Kobayashi S
Gan To Kagaku Ryoho; 1992 Mar; 19(3):333-7. PubMed ID: 1543359
[TBL] [Abstract][Full Text] [Related]
15. [Gastric cancer].
Kinoshita T; Konishi M; Nakagohri T; Takahashi S; Gotouda N
Gan To Kagaku Ryoho; 2006 Mar; 33(3):313-7. PubMed ID: 16531710
[TBL] [Abstract][Full Text] [Related]
16. An individual patient data meta-analysis of adjuvant therapy with uracil-tegafur (UFT) in patients with curatively resected rectal cancer.
Sakamoto J; Hamada C; Yoshida S; Kodaira S; Yasutomi M; Kato T; Oba K; Nakazato H; Saji S; Ohashi Y
Br J Cancer; 2007 Apr; 96(8):1170-7. PubMed ID: 17375049
[TBL] [Abstract][Full Text] [Related]
17. [Chemotherapy for gastric cancer].
Baba H; Kakeji Y; Oki E; Tokunaga E; Ushiro S; Watanabe M; Maehara Y
Gan To Kagaku Ryoho; 2003 Nov; 30(12):1881-8. PubMed ID: 14650954
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of clinical trials on adjuvant chemotherapy for curatively resected gastric cancer].
Kitamura M; Arai K; Iwasaki Y
Gan To Kagaku Ryoho; 1997 Aug; 24(10):1221-9. PubMed ID: 9279340
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine.
Sakuramoto S; Sasako M; Yamaguchi T; Kinoshita T; Fujii M; Nashimoto A; Furukawa H; Nakajima T; Ohashi Y; Imamura H; Higashino M; Yamamura Y; Kurita A; Arai K;
N Engl J Med; 2007 Nov; 357(18):1810-20. PubMed ID: 17978289
[TBL] [Abstract][Full Text] [Related]
20. Randomized clinical trial of adjuvant mitomycin plus tegafur in patients with resected stage III gastric cancer.
Cirera L; Balil A; Batiste-Alentorn E; Tusquets I; Cardona T; Arcusa A; Jolis L; Saigí E; Guasch I; Badia A; Boleda M
J Clin Oncol; 1999 Dec; 17(12):3810-5. PubMed ID: 10577853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
